Table 1 Baseline demographic and clinical information of patients
|  | Total (N = 246) | English Version (n = 160) | Chinese Version (n = 86) | P-value |
|---|---|---|---|---|
Demographic information | ||||
Age, mean (± SD) | 53.4 (±10.0) | 51.2 (± 10.3) | 57.4 (±8.0) | <  0.001# |
Gender, n (%) | Â | Â | Â | 0.192 |
 Female | 230 (93.5) | 152 (95.0) | 78 (90.7) |  |
 Male | 16 (6.5) | 8 (5.0) | 8 (9.3) |  |
Race, n (%) |  |  |  | <  0.001# |
 Chinese | 198 (80.5) | 114 (71.3) | 84 (97.7) |  |
 Non-Chinese |  |  |  |  |
  Malay | 26 (10.6) | 26 (16.3) | 0 (0.0) |  |
  Indians | 12 (4.9) | 12 (7.5) | 0 (0.0) |  |
  Others | 10 (4.1) | 8 (5.0) | 2 (2.3) |  |
Marital Status, n (%) | Â | Â | Â | Â |
 Single | 45 (18.3) | 32 (20.0) | 13 (15.1) | 0.546 |
 Married | 181 (73.6) | 116 (72.5) | 65 (75.6) |  |
 Divorced | 17 (6.9) | 11 (6.9) | 6 (7.0) |  |
 Widowed | 3 (1.2) | 1 (0.6) | 2 (2.3) |  |
Education, n (%) |  |  |  | <  0.001# |
 Low Education | 42 (17.1) | 6 (3.8) | 36 (41.9) |  |
  None | 9 (3.7) | 2 (1.3) | 7 (8.1) |  |
  Primary | 33 (13.4) | 4 (2.5) | 29 (33.7) |  |
 High Education | 204 (82.9) | 154 (96.3) | 50 (58.1) |  |
  Secondary | 111 (45.1) | 73 (45.6) | 38 (44.2) |  |
  Pre-University | 45 (18.3) | 37 (23.1) | 8 (9.3) |  |
  Graduate and Above | 48 (19.5) | 44 (27.5) | 4 (4.7) |  |
Occupation, n (%) | Â | Â | Â | 0.097 |
 Employed | 130 (52.8) | 93 (58.1) | 37 (43.0) |  |
 Unemployed | 90 (36.6) | 53 (33.1) | 37 (43.0) |  |
 Student | 1 (0.4) | 1 (0.6) | 0 (0.0) |  |
 Retired | 25 (10.2) | 13 (8.1) | 12 (14.0) |  |
Clinical Information | ||||
ECOG, n (%) | Â | Â | Â | 0.030# |
 0 | 221 (89.8) | 149 (93.1) | 72 (83.7) |  |
 1 | 15 (6.1) | 6 (3.8) | 9 (10.5) |  |
 Missing | 10 (4.1) | 5 (3.1) | 5 (5.8) |  |
Menopausal status, n (%) |  |  |  | < 0.001# |
 Pre-menopausal | 98 (39.8) | 79 (49.4) | 19 (22.1) |  |
 Post-menopausal | 129 (52.4) | 71 (44.4) | 58 (67.4) |  |
 Not Applicable | 16 (6.5) | 8 (5.0) | 8 (9.3) |  |
 Missing | 3 (1.2) | 2 (1.3) |  |  |
Cancer Diagnosis, n (%) | Â | Â | Â | 0.427 |
 Breast | 225 (91.5) | 148 (92.5) | 77 (89.5) |  |
 Lymphoma | 21 (8.5) | 12 (7.5) | 9 (10.5) |  |
Cancer Stage, n (%) | Â | Â | Â | 0.554 |
 I | 34 (13.8) | 26 (16.3) | 8 (9.3) |  |
 II | 134 (54.5) | 87 (54.4) | 47 (54.7) |  |
 III | 50 (20.3) | 31 (19.4) | 19 (22.1) |  |
 IV | 23 (9.3) | 15 (9.4) | 8 (9.3) |  |
 Unknown | 5 (2.0) | 1 (0.6) | 4 (4.7) |  |
Chemotherapy Regimen, n (%) | Â | Â | Â | 0.819 |
 Anthracycline containing | 132 (53.7) | 85 (53.1) | 47 (54.7) |  |
 Non-anthracycline containing | 114 (46.3) | 75 (46.9) | 39 (45.3) |  |